The ICT Based Prescription of Physical Activity for Oncology Patients at Their Home
Launched by FEDERICO II UNIVERSITY · Jun 6, 2025
Trial Information
Current as of August 22, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is exploring how using technology can help cancer patients stay active at home. Specifically, it looks at whether a program that prescribes physical activity through digital tools can benefit patients with breast or prostate cancer who are preparing for additional treatment. The goal is to see if this approach can improve their overall health and well-being during their cancer journey.
To participate in the trial, patients need to be women diagnosed with breast cancer or men diagnosed with prostate cancer who are eligible for further treatment. It's important to note that patients who have been very active before joining the study will not be included. If eligible, participants will be guided on how to incorporate physical activity into their daily routine using technology, which could make it easier and more convenient for them to stay active while at home. This trial is currently recruiting participants, and it's a great opportunity for eligible patients to contribute to important research that could help improve care for cancer patients in the future.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Female patients affected by breast cancer eligible for adiuvant treatment
- • Male patients affected by prostatic cancer eligible for adiuvant treatment
- Exclusion Criteria:
- • Active life stily before enrollment
About Federico Ii University
Federico II University, located in Naples, Italy, is a prestigious academic institution with a strong emphasis on advanced research and clinical innovation. As a clinical trial sponsor, the university is committed to fostering the development of novel therapeutic interventions and enhancing patient care through rigorous scientific inquiry. With a multidisciplinary approach, Federico II University collaborates with healthcare professionals, researchers, and industry partners to conduct high-quality clinical trials that adhere to ethical standards and regulatory requirements. Its dedication to improving health outcomes is reflected in its robust research programs and commitment to translating scientific findings into clinical practice.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Naples, , Italy
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported